Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract

By Limtrakul Pornngarm   Khantamat Orawan   Pintha Komsak  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 6, 2004-12 ,pp. : 525-530

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals

By Nabekura Tomohiro   Yamaki Takeshi   Ueno Kazuyuki   Kitagawa Shuji  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 867-873

Springer Publishing Company

Access to resources Recommend Favorite

Structure of the multidrug resistance P-glycoprotein

By Higgins C.F.   Callaghan R.   Linton K.J.   Rosenberg M.F.   Ford R.C.  

Seminars in Cancer Biology, Vol. 8, Iss. 3, 1997-06 ,pp. : 135-142

Academic Press

Access to resources Recommend Favorite

Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma

By Coley H.M.   Verrill M.W.   Gregson S.E.   Odell D.E.   Fisher C.   Judson I.R.  

European Journal of Cancer, Vol. 36, Iss. 7, 2000-05 ,pp. : 881-888

Elsevier

Access to resources Recommend Favorite

Syl611, a novel semisynthetic taxane derivative, reverses multidrug resistance by p-glycoprotein inhibition and facilitating inward transmembrane action

By Zhang Yi   Li Hongyan   Wang Hongbo   Su Fuqin   Qu Runjiang   Yin Dali   Dai Jungui   Li Yan   Chen Xiaoguang  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 851-859

Springer Publishing Company

Access to resources Recommend Favorite